Track Paushak Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 3.71 %
Low
645.0
High
728.8
1 Month returns: -12.49 %
Low
634.0
High
783.3
1 Year returns: -17.27 %
Low
342.5
High
834.0
3 Year CAGR: -4.69 %
Low
342.5
High
991.2
5 Year CAGR: -11.97 %
Low
342.5
High
1,550.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Paushak Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Paushak Ltd. Shareholding Pattern
Quarterly breakdown of Paushak Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Paushak Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Paushak Ltd.?
The current share price of Paushak Ltd. is ₹ 674.45 as of 8 Oct 2026.
What is the market capitalisation of Paushak Ltd.?
The market capitalisation of Paushak Ltd. stands at ₹ 1,662.99 Cr.
What is the PE ratio of Paushak Ltd.?
The Price-to-Earnings (PE) ratio of Paushak Ltd. is 39.24 as of the latest trailing twelve months data.
What is the ROE and ROCE of Paushak Ltd.?
Paushak Ltd. has a Return on Equity (ROE) of 8.22% and a Return on Capital Employed (ROCE) of 7.50% as per the latest financial reports.
What is the 52-week high and low of Paushak Ltd.?
The 52-week high of Paushak Ltd. is - and the 52-week low is -.
What is the dividend yield of Paushak Ltd.?
The dividend yield of Paushak Ltd. is 0.37% based on the current market price.
What is the FII and DII holding in Paushak Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 31.46% of Paushak Ltd. shares.
What sector does Paushak Ltd. belong to?
Paushak Ltd. operates in the Chemicals sector.
What is the beta of Paushak Ltd.?
The beta of Paushak Ltd. is 1.21, indicating its price volatility relative to the broader market. Over the past 1 year, Paushak Ltd. has delivered an absolute return of -23.76%.
What is the RSI of Paushak Ltd.?
The 14-day Relative Strength Index (RSI) of Paushak Ltd. is 44.66, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Paushak Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.16 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.11 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 10 financial years
What is Dividend streak?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 39.24 indicates that the stock is expensive on a standalone basis and is at a 50.34% premium to industry median P/E
What is P/E Ratio?
Median: 26.1
Value 39.24
-5.48867.89
Low and declining ROE
The company reported low ROE of 8.22% for 12-month ended 30 Jun 2026 and ROE declined by -307 bps from 1 year ago
What is ROE (FY)?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -20.36% for 12-month ended 30 Jun 2026 and the growth was 36.58 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.37%
What is Dividend yield?
Neutral
High operating margin but declining trend
The company reported strong operating margin of 18.16% for 12-month ended 30 Jun 2026 but operating margin declined by -519 bps from 1 year ago
What is Operating profit margin?
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 14.63% for 12-month ended 30 Jun 2026 and the growth was 1.77 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 12.86
Value 14.63
-39.32704870
Company's earnings are of moderate quality
Earnings quality score of 58.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
58.0 / 100
No red flags found!
No significant red flags found in the stock.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
66.71
66.71
66.71
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
66.97
67.13
67.13
67.28
67.28
67.28
67.28
Indian Promoter
65.87
65.87
65.87
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.13
66.29
66.30
66.44
66.44
66.44
66.44
Foreign Promoter
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
0.84
Institutions
0.00
0.00
0.00
0.01
0.07
0.08
0.04
0.01
0.00
0.00
0.00
0.01
0.01
0.02
0.02
0.13
0.22
0.29
0.34
0.40
0.54
0.53
0.71
0.67
0.25
0.07
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.01
0.07
0.08
0.04
0.00
0.00
0.00
0.00
0.01
0.01
0.02
0.02
0.02
0.02
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.11
0.20
0.29
0.34
0.39
0.53
0.53
0.70
0.67
0.25
0.06
Non-Institution
33.29
33.29
33.29
33.02
32.96
32.95
33.00
33.03
33.03
33.03
33.03
33.02
33.02
33.01
33.01
32.90
32.80
32.74
32.69
32.64
32.32
32.33
32.01
32.05
32.47
32.65
Bodies Corporate
1.06
1.09
1.12
1.13
1.67
1.24
1.23
1.00
0.83
1.09
0.84
0.84
0.96
0.95
0.89
0.87
0.94
0.99
1.00
1.03
1.14
1.17
1.20
1.17
1.21
1.19
Others (incl. Retail)
No. of shareholders
32.23
8,044
32.20
8,212
32.17
9,768
31.89
9,795
31.29
9,835
31.71
11,548
31.77
11,265
32.03
11,626
32.20
12,263
31.94
15,221
32.19
17,472
32.18
19,005
32.06
19,262
32.06
20,059
32.12
21,306
32.03
21,458
31.86
22,372
31.75
21,408
31.69
21,330
31.61
20,604
31.18
20,130
31.16
20,011
30.81
21,853
30.88
21,580
31.26
21,271
31.46
21,254
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Overview of Paushak Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Paushak Limited is an India-based company, which is engaged in the business of specialty chemicals. The Company is engaged in the business of manufacturing phosgene-based specialty chemicals. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate, and others. Its chloroformate products include benzyl chloroformate, ethyl chloroformate, methyl chloroformate, and myristyl chloroformate. The Companys isocyanate products include 2-chloro ethyl isocyanate, phenyl isocyanate, and stearyl isocyanate. Its chloride products include 3 chloropropionyl chloride, diethyl carbamoyl chloride, and dimethyl carbamoyl chloride. The Companys carbonate/carbamate products include polyquaternium, chloromethyl isopropyl carbonate, and bis-(4 nitrophenyl) carbonate. Its other products include tetrabutyl urea, vilsmeier reagent, and dicyclohexyl carbodiimide. It serves various industries, such as pharmaceuticals, agrochemicals, performance, and custom synthesis.
Paushak Limited is an India-based company, which is engaged in the business of specialty chemicals. The Company is engaged in the business of manufacturing phosgene-based specialty chemicals. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate, and others. Its chl...